Andrea. we Actually from have questions you, receive Thank we our shareholders. several did usual as
we questions them go answer through will the we can. as So and
of mentioned niche ANDA additional OTC I OTC the company So goal and be on increase we've is ANDAs pipeline allow tell is to received competitor therapeutic including there we us are status to really less us our before, our ANDAs, our areas will several OTC has the with and questions in add as more that where competition. is the strategy executing the OTC sales on to once So ANDAs ANDA, OTC can mentioned that negotiation? what you
the expect the OTC them coming won't So details in future. something the OTC new now. definitely additional market be market ANDA to ANDAs hearing us from we this in near out us I our hear But the pipeline. in on that from is will discuss on
by utilize the are Novalere price exactly have utilize this to to other our a on question, really mean are with for the is selling product. approved though price lower mean, The we margins. I Amazon, better profit probably FlutiCare goal lowest you our ANDA we again, I our advantage product that partner? recently the how partner, seen going to
second behind there the are We Flonase. competitor out
and a ranked exceedingly world extensive are units We ship day. we an of number
those we to smaller increase and continue allow us FlutiCare our geographically pushing more us competitive for Flonase ranking to payment FlutiCare. of in there batch can markets, to pricing is expand and that's sizes and really better continue and sales a of hopefully on what where having a big with additional better channels. be So help Also will us will terms into
hopefully, on too. news So for look should that the will good from market front potentially
is are other anticipated track The question we discussed that still in date? uplift we the that what our think is I to on NASDAQ to call.
have the for to We satisfy all requirements NASDAQ uplifting.
So which equity have achieve to diligently that and the to towards towards we when satisfy, still we stockholders it addressed needed that. will it be working are hopefully
The supplements? are future, we drugs more other sell very and believe question, sell is really you disease market to have OTC the with on in clear clear much the pricing beginning that from to well-established shift better focus indication with you as is ANDA after from a and easier and after market less brand FDA, products branding compete we a very and go the goal to that we go our originators can or OTC a Yes, the that a market name.
that fast to working we're as So as goal can. we
the our was market. mean, how I where in I look there look in are mean, looking vision more The is add I X% into the niche predict or There drugs hard from portfolio Women, our to we there. out add it's current bring in to three first for second and on your competitor of the bring would question end think what Men and really what for drugs less in an the example net think years is evaluate margin a there in. compete where areas Foam us I go good to years? be and what two to to very players of we how of Minoxidil we're product but is with in portfolio is three that
in know, example out only market in there but are the foam. they Rogaine the and men's only for are for two foam go you the dominates you players additional Amazon if into As there
some us to women's actually price, directly able market to Rogaine up So actually player be penetration at we'll that second in compete the with with area. serious we coming the as be we'll do foam believe X% that lower
the of our East, sixth which competition the potential with I from we Africa? to we have are East is type market, these country market for received the order in for speak drug to So things pipeline. product the before the we a that Middle in the North products have a very announced Zestra the order market. big African think and that is market decision for we we would in bring The is the recently and not the of knowing So Middle making look MENA our little and OTC Algeria a size good for new is products example, that is the North our Algeria potential a we product purchase East market believe and the that there, biggest Middle market $XXX,XXX but market North what to like or our the Africa to Saudi in from of Arabia question,
product expect to product first can that receive that that received $XXX,XXX Saudi have you Arabia and like we for see other order So to the Zestra order magnitude of we close and the countries. the in sold country, when
of market, but the to believe the move we to source and and significant do potential the be will cash a really us up of revenue the that to regions flow profitable actually cover G&A more the that will bottom how add is expenses our more this MENA see situation. we line very and to So the and
extreme I China are I related some the of question the are think the on can address in with we the knowing answers manufactured a increasing actually that situation of is sales the best GlucoGorx that sales on took tariffs how really that's but people the the my the to the how is few product, and tariff GlucoGorx of the if that the see is call on are that ranking to week? The especially Amazon Glucometer going the product by have other increasing So affected that to effect track doing last product. actually
is and our those. I see steadily and next are to those how that think products the a second pricing to to that going tell day. is after day onto that products you is performance selling the four be As to positioning, and is product GlucoGorx third in the We piece extremely of ranked between fact important I and we is those is note I retailer versus large we actually Canada? suite the partner to Canada. not FlutiCare doing can doing to marketing order pause in see I of up out ACON another close think products, team branding, be FlutiCare market our Amazon, the just how in placed our position more to going that really marketing towards really the [indiscernible] specifics now of I certain What product where sales actually this of is well channels, increasing product are there. in we have the on how for And for go of the that, in on us We question and Canada. be on especially sales following them here with And performance and actually well. am the are reinstalling a matter it in product think is expert sales showcase know and peace reviews an
on those actually category towards products will its product. doing moving quarter doing And in once results, in the basis are out good We we're the put think, see extensively are actually how from think being we of I daily market the in that Canada. number second units seller I our Canada top a for
questions questions-and-answers for IR agency? that using as the actually retail basis. IR the dedicated why for the aren't we decisions a taken a We have to have but those actually answer do The I one-to-one order an we all in shareholders have half on actually shareholder directly and agency other questions
to and have and information the continue will directly product. do been have have providing for not with conclude seen be as day on doing as how I updating you a your to and your And to the would as our QX, been to and the that I really to we and retail our And this forward think on we and I the quarter think through public XXXX. want shareholder shareholders of you call think to look we great strategy talking question much you understand and direct the best best to if market from of the towards first mouth sentiment Thank questions you need to and their know we directly our your company, thank you be will I we for able for to to as I believe properly listen next questions directly support I this answer their concerns, you answers shareholders answering the agencies I have those like much we - quarter XXXX. can that, a answer is and way. directly very in